Olainfarm Becomes Olpha And Sets Out European Strategy
Latvian Firm Will Invest €100m Over Five Years As It Eyes Ten-Year €1bn Turnover Goal
Executive Summary
Latvia’s Olainfarm has rebranded itself as Olpha, setting out its ambitions to become a top 10 pharmaceutical company in Europe and achieve turnover of “at least €1bn over the next ten years”.